RxDoctor Payments DataLook up a doctor →

Joseph Lau, APRN

Family · Henderson, NVNPI 1619438389

Payments from drug & device makers

$17,547in general payments, 2019–2025

Across 251 payments — averaging $69.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$1K
  • Abbott$1K
  • Gilead$811
  • Amgen$782
  • plus $9K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)39$2,468
AstraZeneca26$1,857
Novo Nordisk23$1,297
Abbott13$1,081
Gilead8$811
Amgen(2 entities)16$782
Intuitive Surgical4$720
Bayer12$565
GSK5$470
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$398
Lucid Diagnostics Inc.5$369
Idorsia Pharmaceuticals US Inc7$311
Esperion Therapeutics, Inc.4$283
Astellas Pharma US Inc7$264
Incyte Corporation2$250
Argenx US, Inc.2$240
Nestle Healthcare Nutrition Inc.2$236
Ultragenyx Pharmaceutical Inc.2$224
Biohaven Pharmaceutical Holding Company Ltd.5$219
United Therapeutics Corporation2$186
Phathom Pharmaceuticals, Inc.3$173
Dexcom, Inc.2$163
Daiichi Sankyo Inc.2$156
Grifols USA, LLC2$150
Boston Scientific3$150
Beone Medicines USA, Inc.1$149
Biohaven Pharmaceuticals, Inc.3$148
Genmab U.S., Inc.1$125
Viiv Healthcare Company1$125
Vifor Pharma, Inc.1$125
LEO Pharma Inc.1$125
Mannkind Corporation1$125
EMD Serono, Inc.1$124
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$124
Amylyx Pharmaceuticals, Inc.1$122
Kyowa Kirin, Inc.1$122
Actelion Pharmaceuticals US, Inc.1$122
Xeris Pharmaceuticals, Inc.1$122
Avadel CNS Pharmaceuticals, LLC1$120
Pfizer2$118
Takeda Pharmaceuticals U.S.A., Inc.1$118
Lilly USA, LLC2$118
CSL Behring1$118
Redhill Biopharma Inc.1$117
Melinta Therapeutics, LLC1$117
Fresenius Kabi USA, LLC1$116
Jazz Pharmaceuticals Inc.1$111
Otsuka America Pharmaceutical, Inc.1$108
Johnson & Johnson1$108
Boehringer Ingelheim1$104
Corcept Therapeutics1$98
Braeburn Inc.1$93
Merck1$93
Biogen1$92
Recordati_rare_diseases_inc.1$88
UCB, Inc.1$86
Medtronic1$58
Exact Sciences2$51
Amarin Pharma, Inc.1$22
Tactile Systems Technology Inc1$15

How this compares

$17,547 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Medicare billing

Part B allowed, 2024
$33,982
Medicare patients
96
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →